RxDoctor Payments Data

Robert Hoadley

Nurse Practitioner · Fort Wayne, INNPI 1578007480

Payments from drug & device makers

$4,988in general payments, 2019–2025

Across 224 payments — averaging $22.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Viiv Healthcare Company$2K
  • Gilead$1K
  • AbbVie$452
  • AstraZeneca$356
  • Merck$268
  • Janssen Scientific Affairs, LLC$259
  • plus $835 from 13 others

What the payments were for

  • Food & beverage$4,988100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,988 in reported general payments places this provider in the 90th percentile of 2,724 nurse practitioner providers in Indiana.

See all nurse practitioner providers in Indiana

Most prescribed under Part D

DrugClaimsCost to plans & patients
BiktarvyBictegrav/Emtricit/Tenofov Ala130$539,154
DescovyEmtricitabine/Tenofov Alafenam74$166,283
DovatoDolutegravir Sodium/Lamivudine33$134,222
SymtuzaDarunavir/Cob/Emtri/Tenof Alaf24$121,313
TivicayDolutegravir Sodium41$115,565
CabenuvaCabotegravir/Rilpivirine17$100,068
IsentressRaltegravir Potassium36$68,422
PrezcobixDarunavir/Cobicistat23$52,037
FarxigaDapagliflozin Propanediol61$45,239
EvotazAtazanavir Sulfate/Cobicistat22$34,187
PifeltroDoravirine19$33,906
MounjaroTirzepatide22$28,312
OzempicSemaglutide25$25,489
Etravirine20$19,968
EliquisApixaban26$18,898

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GileadBiktarvy, Descovy$1,096$705,437204 claims
Viiv Healthcare CompanyDovato, Tivicay, Cabenuva$1,721$349,85491 claims
MerckIsentress, Pifeltro$268$102,32855 claims
AstraZenecaFarxiga, Breztri Aerosphere$356$56,25474 claims
Johnson & JohnsonPrezcobix$180$52,03723 claims
Lilly USA, LLCMounjaro, Trulicity$144$43,64135 claims
Novo NordiskOzempic$19$25,48925 claims
PfizerEliquis$45$18,89826 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,724 nurse practitioner providers in Indiana.

Other nurse practitioner in Fort Wayne

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →